A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension (Q42727514)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 1, 2011

Language	Label	Description	Also known as
English	A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension	scientific article published on September 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension (English)

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

phase II clinical trial

0 references

open-angle glaucoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Susan Raber

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Rachel Courtney

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Min Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ronald A. Schachar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21851167

9 December 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

September 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21851167

9 December 2024

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/02713683.2011.593725

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Current Eye Research

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

809-817

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Tachykinins as enhancers of prostaglandin E2-induced intraocular inflammation.

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Blood-aqueous barrier in prostaglandin EP2 receptor knockout mice

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Ocular inflammatory responses in the EP2 and EP4 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Detection of EP2, EP4, and FP receptors in human ciliary epithelial and ciliary muscle cells

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues--a comparative immunohistochemical study

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Effect of latanoprost or 8-iso prostaglandin E2 alone and in combination on intraocular pressure in glaucomatous monkey eyes

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2011.593725

21 January 2018

Investigative Ophthalmology Visual Science

4

22

588

author name string

Stern FA

publication date

1982

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Investigative Ophthalmology Visual Science

5

24

312

author name string

Bito LZ

publication date

1983

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Investigative Ophthalmology Visual Science

6

24

376

author name string

Bito LZ

publication date

1983

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Investigative Ophthalmology Visual Science

10

31

2463

author name string

Protzman CE

publication date

1990

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Immunolocalization of prostanoid EP receptor isotypes in human trabecular meshwork

16

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Investigative Ophthalmology Visual Science

17

43

1475

author name string

Schlotzer-Schrehardt U

publication date

2002

1 reference

10.3109/02713683.2011.593725

https://api.crossref.org/works/10.3109/02713683.2011.593725

9 December 2024

Identifiers

10.3109/02713683.2011.593725

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42727514&oldid=2285418226"